MAM
Vikram Sakhuja to take up executive director position at Madison Media based in New Delhi
MUMBAI: With Ajit Varghese heading back to Madison Media, this time as partner and group CEO of Madison Media & OOH, questions were being asked about the role of long-serving group CEO Vikram Sakhuja. The suspense was laid to rest a short while ago when Madison promoter Sam Balsara confirmed that Sakhuja will continue as executive director, focusing on building organisational capability from New Delhi.
Meanwhile Balsara is quite confident about Varghese’s appointment as the agency’s leader. “Ajit has all the credentials to steer an agency like Madison into the future,” he said, citing Varghese’s stints at Madison, GroupM, a digital publisher, and most recently JioStar. Like Sakhuja, Varghese will hold a stake in the business.
Calling it a “homecoming”, Varghese said he was returning with a renewed mission. “The world of media is transforming at lightning speed, and Madison is uniquely poised to lead with its client-first thinking, independent spirit, and deep talent,” he said.
Madison Media, India’s largest homegrown communications agency, is ranked the world’s fourth-largest independent media agency by Recma. It manages media planning and buying for marquee clients including Marico, Asian Paints, Titan, TVS, Godrej Properties, Pidilite, Ceat, and the BJP. Through its 11 units, Madison World served some 500 advertisers last year.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
